The Antiviral Compound PSP Inhibits HIV-1 Entry via PKR-Dependent Activation in Monocytic Cells.

Alvarez-Rivera E, Rodr?guez-Valent?n M, Boukli NM. The Antiviral Compound PSP Inhibits HIV-1 Entry via PKR-Dependent Activation in Monocytic Cells. Viruses. 2023 03 22; 15(3).

View in: PubMed

subject areas

Actin Depolymerizing Factors
Actins
Antiviral Agents
eIF-2 Kinase
Endoribonucleases
HIV-1
Humans
Phosphorylation
Protein Kinases
Proteoglycans

authors with profiles

Nawal M. Boukli

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support